Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05970016 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 21, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Enrollment target: 40 to 56 Primary completion date: Mar 30, 2025 to Jul 30, 2025 · Completion date: Sep 30, 2025 to Dec 30, 2025 · Interventions: TCC1727 tablet (Drug) to TCC1727 tablet（1） (Drug), TCC1727 tablet（2） (Drug) · 2 morev4 Show 5 more changesShow less
    • Primary completion date: Mar 30, 2025 to Jul 30, 2025
    • Completion date: Sep 30, 2025 to Dec 30, 2025
    • Interventions: TCC1727 tablet (Drug) to TCC1727 tablet（1） (Drug), TCC1727 tablet（2） (Drug)
    • Site details revised
    • Study arms: 7 to 11
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruiting Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a 2-part, phase I/II, open-label, multicenter study designed to evaluate the safety, PK, PD and preliminary efficacy of TCC1727 tablets administered orally QD.
Trial Details
NCT Number NCT05970016
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Conditions Patients with Advanced Solid Tumors
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov